Nicholas Focil
Professional Summary
Professional Overview
Nicholas Focil is a seasoned healthcare executive with extensive experience in medical research, innovation, and strategic leadership. As the CEO of FOMAT Medical Research and the Chairman & Co-Founder of AlzWell, he is a driving force in advancing cutting-edge treatments and improving patient outcomes within the pharmaceutical and biotechnology industries.
Experience Summary
Current Roles
As the CEO of FOMAT Medical Research since 2019, Nicholas is responsible for overseeing the company's global clinical trial operations, driving strategic growth initiatives, and fostering collaborative partnerships with leading pharmaceutical and biotech companies. Under his leadership, FOMAT has expanded its international footprint and executed numerous successful clinical trials, contributing to the development of innovative therapies.
As the Chairman & Co-Founder of AlzWell, a company focused on addressing the challenges of Alzheimer's disease, Nicholas leads the development of groundbreaking solutions and advocates for improved patient care and caregiver support. Through his visionary approach, AlzWell has garnered industry recognition and secured strategic investments to accelerate its mission.
Additionally, Nicholas serves as a Board Member at hyperCORE International, a leading network of clinical research sites, where he leverages his expertise to enhance clinical trial efficiency and patient engagement.
Career Progression
Prior to his current roles, Nicholas held the position of Managing Director at FOMAT Medical Research, where he played a pivotal role in expanding the company's global footprint and overseeing complex multi-site clinical trials. He has also contributed as a Co-Host for the popular podcast "The Monthly Dose," sharing his insights on the latest developments in the healthcare industry.
Earlier in his career, Nicholas gained valuable experience as a Research Associate at Medtronic, where he contributed to the advancement of medical devices and therapeutic solutions.
Academic Background
Nicholas holds a Bachelor's degree in Biological Sciences from a leading university, where he graduated with distinction and demonstrated a strong aptitude for research and innovation.
Areas of Expertise
- Clinical trial management and execution
- Pharmaceutical and biotechnology industry strategy
- Alzheimer's disease research and patient care solutions
- Global business development and strategic partnerships
- Healthcare innovation and technology implementation
- Effective team leadership and organizational growth
Professional Impact
Under Nicholas's leadership, FOMAT Medical Research has become a recognized leader in the clinical trial industry, consistently delivering high-quality results and contributing to the advancement of promising therapies. His strategic vision and collaborative approach have enabled the company to secure multiple high-profile partnerships with leading pharmaceutical and biotech firms.
At AlzWell, Nicholas's dedication to addressing the challenges of Alzheimer's disease has led to the development of groundbreaking solutions that have received industry acclaim and attracted significant investment. His advocacy efforts have also helped raise awareness and improve support for patients and caregivers.
Conclusion
With a proven track record of success in the healthcare and medical research sectors, Nicholas Focil is a respected leader known for his strategic vision, operational excellence, and commitment to driving innovation. As he continues to guide FOMAT Medical Research and AlzWell, his expertise and leadership will play a crucial role in shaping the future of the industry and improving patient outcomes worldwide.
